Other drugs such as bortezomib, were also involved in the up-regulation of NKG2D and DNAM-1 ligand expression by MM cells, leading to the enhancement of the Vδ2 T cell cytotoxic effect (45). This evidence concerns the gene KLRK1 and Miyoshi myopathy.